by jowen | Sep 29, 2018 | Cancer, Glucans
Ross Immunopharmacology 1999 — Article details beta Glucans mode of action on the immune system. Article describes how CR3 binding by beta Glucan begins a broad immune response especially to cancer tumor cells which the immune system might ordinarily only partially...
by jowen | Sep 29, 2018 | Diabetes, Glucans
Pathology Discovery 2018 – Richter Josef, Závorková Martina, Vetvicka Vaclav*, Král Vlastimil, Stiborova Ivana, Liehneová Ivana and Pohořská Jitka and Rajnohova Dobiasova Lucie. Pathology Discovery, vol. 5, no. 1, 2018, p. 1., doi:10.7243/2052-7896-6-1. This...
by jowen | Sep 28, 2018 | Glucans, Immunity/Immune Response/Immune Response
Novak Journal Immunotoxicology 2008 — B1,3-Glucan: Silver Bullet or Hot Air. Article is an historical perspective of beta glucan’s evolution as an accepted biological response modifier. Article also describes the known Mode of Action of beta glucans. Read...
by jowen | Sep 28, 2018 | Cancer, Glucans, Immunity/Immune Response/Immune Response
North American Journal of Medical Sciences 2016 Volume 8, Issue 2, February 2016 — Addition of Selenium Improves Immunomodulative Effects of Glucan. “Using two different murine models of cancer, we showed that the Selenium (Se)/glucan combination strongly suppressed...
by jowen | Sep 28, 2018 | Cancer, Glucans
Journal of Tumor 2016 — A randomized, double-blind, placebo-controlled trial compared β-glucan #300 and a placebo in people after complex surgical, radiation and/or chemotherapy treatment of cancer. Starting points of cancer disease are closely associated with...
by jowen | Sep 28, 2018 | Cancer, Glucans
Journal of Tumor 2015 – “Regulation of Hematopoiesis in Cancer Patients: Placebo-Driven, Double-Blind Clinical Trials of β-Glucan.”- This article focuses on the effects of glucan supplementation on cancer patients in post-treatment periods to try to alleviate anemia....
